home
Corporate
Business
History
Management
Shareholders
Location and Infrastructures
Corporate Governance
Environment, Health & Safety
Products
Advanced Breast Cancer
Severe Hepatic Conditions
Triple Negative Breast Cancer
Technology
Tribody Technology
Scientific Publications
Development
Process Development
cGMP / cGLP production
Quality Systems
Stability Studies
CMC / CTD
Media
Press Releases
In The News
Contacts
2010
2009
2008
2007
2006
USA and EP Patents granted for CAB051 - a novel anti-HER2 mini-antibody
May 18, 2010
Biotecnol to Participate at the 28th Annual J.P. Morgan Healthcare Conference
Jan 4, 2010